Antibiotic Resistant Bacteria Succumb to Treatment with Unique Natural Clay
By LabMedica International staff writers Posted on 07 Feb 2016 |

Image: Naturally occurring clay from Kisameet Bay, Canada, exhibits potent antibacterial activity against multidrug-resistant pathogens (Photo courtesy of Kisameet Glacial Clay Inc.).
A team of Canadian medical microbiologists has demonstrated the potential use of a unique type of natural clay for treating pathogenic bacteria that have become resistant to the commonly used antibiotics.
Medicinal and therapeutic use of mineral products has impacted human health for thousands of years, and pure clay minerals, such as smectite and illite, are nanomaterials of geological origin. The intentional consumption of earth materials, such as clays, by humans and animals is known as geophagy, a complex behavior, largely attributed to religious beliefs, cultural practices, psychological disorders, cosmetics, dietary/nutritional needs, and medicinal benefits. Early research focused on the extraordinary adsorptive properties of clay minerals and the health benefits recognized in aiding digestive processes and cleansing and protecting the skin. Due to the small particle size (less than two micrometers), these natural geological products have a vast surface area (hundreds of square meters per gram of clay) with high concentrations of ions and compounds located on the surfaces. Despite the clear, beneficial effects on human health related to ridding the body of foreign substances, few studies have investigated the antibacterial properties of clay minerals.
Investigators at the University of British Columbia (Canada) worked with Kisameet clay, which was found in a shallow five-acre granite basin located about 400 kilometers north of Vancouver, Canada. This material was valued by indigenous peoples for its therapeutic properties for treatment of a wide variety of disorders including ulcerative colitis, duodenal ulcer, arthritis, neuritis, phlebitis, skin irritation, and burns.
In particular the investigators examined the effect of the clay on the bacteria comprising the ESKAPE group (Enterococcus faecium, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species), which have developed antibiotic resistance and cause the majority of nosocomial infections.
They reported in the January 26, 2016, online edition of the journal mBio that in vitro tests of the clay suspended in water showed that it was capable of killed 16 strains of ESKAPE bacteria from various sources.
"Infections caused by ESKAPE bacteria are essentially untreatable and contribute to increasing mortality in hospitals," said senior author Dr. Julian Davies, professor emeritus in microbiology at the University of British Columbia. "After 50 years of over-using and misusing antibiotics, ancient medicinals and other natural mineral-based agents may provide new weapons in the battle against multidrug-resistant pathogens."
Related Links:
University of British Columbia
Medicinal and therapeutic use of mineral products has impacted human health for thousands of years, and pure clay minerals, such as smectite and illite, are nanomaterials of geological origin. The intentional consumption of earth materials, such as clays, by humans and animals is known as geophagy, a complex behavior, largely attributed to religious beliefs, cultural practices, psychological disorders, cosmetics, dietary/nutritional needs, and medicinal benefits. Early research focused on the extraordinary adsorptive properties of clay minerals and the health benefits recognized in aiding digestive processes and cleansing and protecting the skin. Due to the small particle size (less than two micrometers), these natural geological products have a vast surface area (hundreds of square meters per gram of clay) with high concentrations of ions and compounds located on the surfaces. Despite the clear, beneficial effects on human health related to ridding the body of foreign substances, few studies have investigated the antibacterial properties of clay minerals.
Investigators at the University of British Columbia (Canada) worked with Kisameet clay, which was found in a shallow five-acre granite basin located about 400 kilometers north of Vancouver, Canada. This material was valued by indigenous peoples for its therapeutic properties for treatment of a wide variety of disorders including ulcerative colitis, duodenal ulcer, arthritis, neuritis, phlebitis, skin irritation, and burns.
In particular the investigators examined the effect of the clay on the bacteria comprising the ESKAPE group (Enterococcus faecium, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species), which have developed antibiotic resistance and cause the majority of nosocomial infections.
They reported in the January 26, 2016, online edition of the journal mBio that in vitro tests of the clay suspended in water showed that it was capable of killed 16 strains of ESKAPE bacteria from various sources.
"Infections caused by ESKAPE bacteria are essentially untreatable and contribute to increasing mortality in hospitals," said senior author Dr. Julian Davies, professor emeritus in microbiology at the University of British Columbia. "After 50 years of over-using and misusing antibiotics, ancient medicinals and other natural mineral-based agents may provide new weapons in the battle against multidrug-resistant pathogens."
Related Links:
University of British Columbia
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channelMass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication
Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more
First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read more
Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read moreMolecular Diagnostics
view channel
First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis
Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more
New Molecular Label to Help Develop Simpler and Faster Tuberculosis Tests
Tuberculosis (TB), the deadliest infectious disease globally, is responsible for infecting an estimated 10 million people each year and causing over 1 million deaths annually. While chest X-rays and molecular... Read more
Biomarker Discovery Paves Way for Blood Tests to Detect and Treat Osteoarthritis
The number of individuals affected by osteoarthritis is projected to exceed 1 billion by 2050. The primary risk factor for this common, often painful chronic joint condition is aging, and, like aging itself,... Read moreHematology
view channel
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, led to 1.25 million deaths in 2023, with 13% of those occurring in people living with HIV. The current primary diagnostic method for... Read more
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read morePathology
view channel
Groundbreaking Chest Pain Triage Algorithm to Transform Cardiac Care
Cardiovascular disease is responsible for a third of all deaths worldwide, and chest pain is the second most common reason for emergency department (ED) visits. With EDs often being some of the busiest... Read more
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read moreTechnology
view channel
Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more